Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · IEX Real-Time Price · USD
10.08
-0.10 (-0.98%)
At close: Jul 19, 2024, 4:00 PM
10.52
+0.44 (4.37%)
Pre-market: Jul 22, 2024, 9:10 AM EDT
Cassava Sciences Employees
Cassava Sciences had 29 employees as of December 31, 2023. The number of employees increased by 3 or 11.54% compared to the previous year.
Employees
29
Change (1Y)
3
Growth (1Y)
11.54%
Revenue / Employee
n/a
Profits / Employee
-$1,651,828
Market Cap
483.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Enhabit | 10,800 |
Treace Medical Concepts | 516 |
biote | 194 |
Fate Therapeutics | 181 |
MaxCyte | 143 |
EyePoint Pharmaceuticals | 121 |
Theravance Biopharma | 99 |
Third Harmonic Bio | 30 |
SAVA News
- 5 days ago - Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives - GlobeNewsWire
- 14 days ago - Top 5 Health Care Stocks That May Explode In July - Benzinga
- 20 days ago - Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation - Benzinga
- 21 days ago - Cassava Sciences forms internal panel after US probe into two employees - Reuters
- 21 days ago - Cassava Sciences stock forecast: is it safe to buy the SAVA dip? - Invezz
- 23 days ago - Cassava Sciences shares fall after onetime advisor indicted on fraud charges - Market Watch
- 23 days ago - Cassava Sciences Shares Plunge on Indictment Against Former Advisor - Barrons
- 23 days ago - Cassava Sciences Issues Statement on Former Science Advisor - GlobeNewsWire